{
 "generic_name": "Lorazepam Injection",
 "slug": "lorazepam-injection",
 "brand_names": [
  "Lorazepam"
 ],
 "fda_status": [
  "Current"
 ],
 "last_fda_update": "09/22/2026",
 "first_posted": "05/03/2018",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "65219-368-02",
   "presentation": "Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release September 2026. Check wholesalers for inventory."
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6046-10",
   "presentation": "Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: TBD"
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6000-10",
   "presentation": "Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: TBD"
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6044-25",
   "presentation": "Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Estimated recovery: TBD"
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6001-25",
   "presentation": "Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Estimated recovery: TBD"
  },
  {
   "company": "Amphastar Pharmaceuticals, Inc.",
   "package_ndc": "76329-8261-1",
   "presentation": "Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1985-30",
   "presentation": "Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Limited Supply Available. Next Delivery: July 2027; Estimated Recovery: September 2027"
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6003-25",
   "presentation": "Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: TBD"
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6045-25",
   "presentation": "Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: TBD"
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6047-10",
   "presentation": "Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: TBD"
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6002-10",
   "presentation": "Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: TBD"
  }
 ],
 "changes": []
}